• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . TNFα aggravates detrimental effects of SARS-CoV-2 infection in the liver

tetano

Editor, Senior Moderator
Front Immunol


. 2023 Mar 31;14:1151937.
doi: 10.3389/fimmu.2023.1151937. eCollection 2023.
TNFα aggravates detrimental effects of SARS-CoV-2 infection in the liver


Jöran Lücke[SUP] 1 2 3 [/SUP], Mikolaj Nawrocki[SUP] 1 2 4 [/SUP], Josa Schnell[SUP] 1 2 [/SUP], Nicholas Meins[SUP] 1 2 [/SUP], Fabian Heinrich[SUP] 5 6 [/SUP], Tao Zhang[SUP] 1 2 [/SUP], Franziska Bertram[SUP] 1 2 6 [/SUP], Morsal Sabihi[SUP] 1 2 [/SUP], Marius Böttcher[SUP] 1 2 4 [/SUP], Tom Blankenburg[SUP] 1 2 [/SUP], Marie Pfaff[SUP] 3 [/SUP], Sara Notz[SUP] 3 [/SUP], Jan Kempski[SUP] 1 2 4 7 [/SUP], Matthias Reeh[SUP] 3 [/SUP], Stefan Wolter[SUP] 3 [/SUP], Oliver Mann[SUP] 3 [/SUP], Jakob R Izbicki[SUP] 3 [/SUP], Marc Lütgehetmann[SUP] 6 [/SUP], Anna Duprée[SUP] 3 [/SUP], Anastasios D Giannou[SUP] 1 2 3 [/SUP], Benjamin Ondruschka[SUP] 5 [/SUP], Samuel Huber[SUP] 1 2 4 [/SUP]



Affiliations

Abstract

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus does not only lead to pulmonary infection but can also infect other organs such as the gut, the kidney, or the liver. Recent studies confirmed that severe cases of COVID-19 are often associated with liver damage and liver failure, as well as the systemic upregulation of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNFα). However, the impact these immune mediators in the liver have on patient survival during SARS-CoV-2 infection is currently unknown. Here, by performing a post-mortem analysis of 45 patients that died from a SARS-CoV-2 infection, we find that an increased expression of TNFA in the liver is associated with elevated mortality. Using publicly available single-cell sequencing datasets, we determined that Kupffer cells and monocytes are the main sources of this TNFα production. Further analysis revealed that TNFα signaling led to the upregulation of pro-inflammatory genes that are associated with an unfavorable outcome. Moreover, high levels of TNFA in the liver were associated with lower levels of interferon alpha and interferon beta. Thus, TNFα signaling in the infected SARS-CoV-2 liver correlates with reduced interferon levels and overall survival time.

Keywords: Cxcl3; Cxcl8; Icam1; SARS-CoV-2; TNFa; liver; post-mortem.
 
Back
Top Bottom